Concorde International Group Ltd shares rise 6.12% premarket after Concord Healthcare Group Co Ltd announced plans to increase.

Concorde International Group Ltd rose 6.12% in premarket trading, with Concord Healthcare Group Co Ltd, a China-based company primarily engaged in providing medical services to cancer patients, announcing plans to increase its operations. The company conducts its business through two segments: the Hospital Business segment, which serves cancer patients through self-operated medical institutions, and the Medical Equipment, Software and Related Services segment, which is engaged in the sales and installation of medical equipment and software, management and technical support, and operating lease. The company mainly conducts its businesses in the domestic market.